欧盟HMA药品数据库（European Union HMA Authorisation of Medicines DataBase）
MR编号
DE/H/0425/004
药品名称
Simva TAD 40 mg
活性成分
simvastatin 40.0 mg
剂型
Film-coated tablet
上市许可持有人
TAD Pharma GmbH Heinz-Lohmann-Str. 5 D-27472 Cuxhaven
参考成员国 - 产品名称
Germany (DE)
互认成员国 - 产品名称
Cyprus (CY)
simva tad 40mg 24m0184
Belgium (BE)
Ireland (IE)
Italy (IT)
Latvia (LV)
Simva TAD 40 mg film-coated tablets
Lithuania (LT)
Simva TAD 40 mg plėvele dengtos tabletės
Hungary (HU)
Simva TAD 40 mg tabletta
许可日期
2003/10/13
最近更新日期
2019/07/01
药物ATC编码
C CARDIOVASCULAR SYSTEM
C10 LIPID MODIFYING AGENTS
C10A LIPID MODIFYING AGENTS, PLAIN
C10AA HMG CoA reductase inhibitors
C10AA01 simvastatin
申请类型
TypeLevel1：
Abridged
TypeLevel2：
Additional Strength/Form
TypeLevel3：
Generic Article 4.8(a)(iii), first paragraph
TypeLevel4：
Chemical Substance
TypeLevel5：
Prescription Only
附件文件下载
Final Product Information
|
common_final_spc_0425_002__V027
Date of last change:2024/09/06
Final Product Information
|
common_final_spc_0425_003__V027
Date of last change:2024/09/06
Final Product Information
|
common_final_spc_0425_004__V027
Date of last change:2024/09/06
Final SPC
|
common_final_spc_425_002_
Date of last change:2024/09/06
Final SPC
|
common_final_spc_425_003_
Date of last change:2024/09/06
市场状态
Positive
©2006-2024
Drugfuture
->
European Union HMA Authorisation of Medicines DataBase